LX-1031

SynDRA canonical compound SYN0079154 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	TPH1
Mechanism of action	tryptophan hydroxylase inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

AURKA

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

ATXN2

Cross-references

PubChem CID: 23633604
ChEMBL: CHEMBL4303338
DrugBank: DB05199
TTD: D0H9WR
LINCS BRD: BRD-K32101625

Synonyms

LX1031
J08E1J78GK
RefChem:154456
DTXCID00164035
UNII-J08E1J78GK
C28H25F3N4O4
SCHEMBL308718
orb1308106
SCHEMBL29391423
BDBM445705
EX-A14839
MFCD19443125
AKOS027307781
CS-0452
US10683309, Example LX1031
NCGC00378785-01
HY-13041
MS-29932
T15796
BRD-K32101625-001-01-6
DB-079969
SCHEMBL2364480
SB17168
XNMUICFMGGQSMZ-UHFFFAOYSA-N
SCHEMBL308719
BDBM357742
US10214530, LX1031

Look up LX-1031 in the interactive SynDRA portal →